feed,title,long_url,short_url
Benzinga,Bristol Myers' Opdivo Shows Improved Clinical Benefits In Bladder Cancer At Three Years,https://benzinga.com/general/biotech/23/02/30963196/bristol-myers-opdivo-shows-improved-clinical-benefits-in-bladder-cancer-at-three-years,https://da.gd/qafSc5
